🇺🇸 FDA

Intelligence Platform

Patents

Browse 793 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8476281

Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyr

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8471014

Process of making gyrase and topoisomerase IV inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8425459

Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast

Lutonix, Inc. · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8426426

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8420650

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415400

Cross-linked ionic core micelles

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404852

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394803

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8391959

Composition for improving efficiency of drug delivery

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372380

In vivo imaging of sulfotransferases

The Regents of the University of California · Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8354450

Creatine oral supplementation using creatine hydrochloride salt

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8343549

Therapeutic uses of Dunaliella powder

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337813

Contrast agents

Northwestern University · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8338624

Isoflavone derivatives and uses thereof

Medical Research and Infrastructure Fund of Tel-Aviv Sourasky Medical Center · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8333959

Ex-vivo application of solid microparticulate therapeutic agents

Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8334409

Process for purifying rasagiline base

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8329745

Small molecule inhibitors of ghrelin O-acyltransferase

The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324385

Diacylglycerol acyltransferase inhibitors

Madrigal Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288530

Method of preparing macromolecular contrast agents and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268849

Multifunctional Antioxidants and methods of use thereof

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8257915

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8247563

Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8247410

Pyrimidine substituted purine derivatives

VERASTEM, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8242076

Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and re

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted